Archives

HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy

B Industry veteran brings 25+ years of global clinical leadership from Ferring, Novartis, NIBR, Bayer, and SixPeaks Bio to support HERVolution’s cardiometabolic pipeline Tankó’s strategic scientific expertise will be critical…

Read MoreHERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy